TPWA
IDXX icon

Twin Peaks Wealth Advisors’s Idexx Laboratories IDXX Stock Holding History

Twin Peaks Wealth Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-47
Closed -$26.4K – 1146
2026
Q1 		$26.4K Buy
+47
New +$30.1K 0.01% 613
2025
Q3 		– Sell
-32
Closed -$20.9K – 1081
2025
Q2 		$20.9K Buy
+32
New +$15.3K 0.01% 593

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Twin Peaks Wealth Advisors's IDXX Position: Q2 2026 in Review

Twin Peaks Wealth Advisors sold out of Idexx Laboratories (IDXX) in Q2 2026, closing a stake of 47 shares — an estimated $26.4K sold.

Twin Peaks Wealth Advisors first reported a position in IDXX in Q2 2025 and held it in 2 quarters. The position peaked at $26.4K in Q1 2026. 1,305 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Twin Peaks Wealth Advisors reported no remaining Idexx Laboratories position as of Q2 2026 after selling out during the quarter.
  • Twin Peaks Wealth Advisors sold 47 Idexx Laboratories shares in Q2 2026, an estimated $26.4K.
  • Twin Peaks Wealth Advisors first reported a position in Idexx Laboratories in Q2 2025 and held it in 2 quarters.
  • Twin Peaks Wealth Advisors's Idexx Laboratories position peaked at $26.4K in Q1 2026.
  • 1,305 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Twin Peaks Wealth Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.